Insider Transactions in Q2 2020 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2020
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
4,912
-19.72%
|
$368,400
$75.18 P/Share
|
|
Jun 25
2020
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,912
+16.47%
|
$58,944
$12.57 P/Share
|
|
Jun 24
2020
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
65,088
-22.02%
|
$4,881,600
$75.91 P/Share
|
|
Jun 24
2020
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,088
+38.0%
|
$585,792
$9.22 P/Share
|
|
Jun 23
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
50,000
-6.68%
|
$3,750,000
$75.0 P/Share
|
|
Jun 23
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
6,929
-17.03%
|
$519,675
$75.2 P/Share
|
|
Jun 23
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
10,000
-1.71%
|
$750,000
$75.35 P/Share
|
|
Jun 22
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
229
-0.56%
|
$16,030
$70.14 P/Share
|
|
Jun 22
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
10,000
-1.68%
|
$720,000
$72.51 P/Share
|
|
Jun 02
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.45%
|
$51,414
$66.26 P/Share
|
|
Jun 01
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,275
-3.14%
|
$1,105,600
$64.48 P/Share
|
|
Jun 01
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,275
+8.38%
|
$17,275
$1.81 P/Share
|
|
May 26
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
6,100
-12.98%
|
$427,000
$70.14 P/Share
|
|
May 26
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
36,616
-4.67%
|
$2,563,120
$70.27 P/Share
|
|
May 22
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
600
-1.26%
|
$42,000
$70.05 P/Share
|
|
May 22
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
13,384
-1.68%
|
$936,880
$70.01 P/Share
|
|
May 20
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,693
-5.87%
|
$695,045
$65.28 P/Share
|
|
May 20
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,693
+5.54%
|
$10,693
$1.81 P/Share
|
|
May 19
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,307
-2.45%
|
$279,955
$65.16 P/Share
|
|
May 19
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,307
+2.39%
|
$4,307
$1.81 P/Share
|
|
May 19
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
50,000
-5.9%
|
$3,250,000
$65.0 P/Share
|
|
May 11
2020
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
25,000
-28.67%
|
$1,500,000
$60.73 P/Share
|
|
May 11
2020
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+35.71%
|
$125,000
$5.86 P/Share
|